Involvement of P38 MAP kinase in the augmentation of UVB-mediated apoptosis via the epidermal platelet-activating factor receptor

Archives of Dermatological Research

Volumn 299, Issue 5-6, 2007, Pages 263-266

  Landis, Megan ^a   Yi, Qiaofang ^a   Hyatt, Ann Marie ^a   Travers, Angela R ^a   Lewis, Davina A ^a   Travers, Jeffrey B ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; p38 MAP kinase; Platelet activating factor; UVB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; EPIDERMIS; EPITHELIOID CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION;

APOPTOSIS; EPIDERMIS; HUMANS; KB CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 34547697906     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0753-x     Document Type: Article

References (14)

1. Ahn KS, Hahn BS, Kwack K, Lee EB, Kim YS (2006) Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes Eur J Pharmacol 537:1-11
2. Barber L, Spandau D, Rathman S, Murphy R, Johnson C, Kelley S, Hurwitz S, Travers J (1998) Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line J Biol Chem 273:18891-18897
3. Ishii S, Nagase T, Shimizu T (2002) Platelet-activating factor receptor. Prost Other Lipid Mediat 68:599-609
4. Kripke ML, Anathaswamy H (2003) Carcinogenesis: ultraviolet radiation. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Dermatology in general Medicine. McGraw-Hill, New York, pp 797-804
5. Li T, Southall MD, Yi Q, Pei Y, Lewis D, Al-Hassani M, Spandau D, Travers JB (2003) The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem 278:16614-16621
6. Marathe G, Johnson C, Billings SD, Southall MD, Pei Y, Spandau D, Murphy RC, Zimmerman GA, McIntyre TM, Travers JB (2005) Ultraviolet B radiation generates PAF-like phospholipid mediators underlying cutaneous damage J Biol Chem 280:35448-35455
7. Marques SA, Dy L, Southall MD, Yi Q, Smietana E, Kapur R, Marques M, Travers JB, Spandau D (2002) The platelet-activating factor receptor activates the ERK MAP kinase and induces proliferation of epidermal cells through an EGF Receptor-dependent pathway. J Pharmacol Exp Therapeut 300:1026-1035
8. Papoutsaki M, Moretti F, Lanza M, Marinari B, Sartorelli V, Guerrini L, Chimenti S, Levrero M, Costanzo A (2005) A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes. Oncogene 24(46):6970-6975
9. Pei Y, Barber LA, Murphy RC, Johnson CA, Kelley SW, Dy LC, Fertel RH, Nguyen TM, Williams DA, Travers JB (1998) Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161: 1954-1961
10. Southall M, Isenberg J, Nakshatri H, Yi Q, Pei Y, Spandau D, Travers J (2001) The platelet-activating factor receptor protects epidermal cells from tumor necrosis factor (TNF) α and TNF-related apoptosis inducing ligand-induced apoptosis through an NF-kB-dependent process. J Biol Chem 276: 45548-45554
11. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Lin Lab Sci 40(6):643-672
12. Travers J, Huff J, Rola-Plaeszczynski M, Gelfand E, Morelli J, Murphy R (1995) Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105:816-823
13. Walterscheid JP, Ullrich SE, Ngheim DX (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195:171-179
14. Wolf P, Ngheim DX, Walterscheid JP, Byrne S, Matsumura Y, Matsumura Y, Bucana C, Ananthaswamy HN, Ullrich SE (2006) Platelet-activating factor (PAF) is crucial in psoralen + UVA (PUVA)-induced immune suppression, inflammation, and apoptosis. Am J Path 169(3):795-805